Bioscience Animal Health PCL

BIS · BK · Consumer Defensive / Packaged Foods

2.12THB-0.04 (-1.85%)

Price History

Full chart

Market Stats

Previous Close2.16

Open2.16

Day Range2.08 – 2.16

52-Week Range1.51 – 3.40

Volume154.30K

Market Cap803.84M

P/E (TTM)23.27

Forward P/E0.00

EPS0.11

Dividend Yield4.69%

Beta0.51

50-Day Avg2.37

200-Day Avg2.11

About

Bioscience Animal Health Public Company Limited, together with its subsidiaries, manufactures, imports, and distributes pharmaceutical supplies, devices, equipment, and products for livestock and companion animals in Thailand and internationally. The company offers antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company offers farm production consultant; disease prevention and monitoring; serological diagnostic; farm biosecurity and sanitation; raw material, feed chemical, physical, and mycotoxin analysis; feed formulation; repacking and remixing and OEM Product; and farm human resource and training services. Further, it provides animal health products; nutrition products; diagnostic products, such as test kits and diagnostic medical devices; consulting services about testing method, installation, and laboratory protocol; complete feed products; ingredient products; and animal carcass incinerators. The company serves feed mills, integrated farms, agents, veterinary hospitals and clinics, pet shops, and modern trade and e-commerce customers. It exports its products. Bioscience Animal Health Public Company Limited was incorporated in 2004 and is headquartered in Nonthaburi, Thailand.

Company Details

SectorConsumer Defensive
IndustryPackaged Foods
CEOMr. Poramase Kampak D.V.M.
Employees0
HeadquartersBIS Tower, Nonthaburi, Thailand, 11120, Thailand
Websitehttps://www.bis-group.com

Leadership

Mr. Poramase Kampak D.V.M.CEO, Member of Executive Board & Executive Director · b. 1975
Mr. Dhanawat Khongjaroensombat D.V.M.Chairman of Executive Board & Executive Director · b. 1971
Mr. Rungroj Thavontanakul D.V.M.CAO, Company Secretary, Member of Executive Board, Head of IR & Executive Director · b. 1978
Mr. Paphon SirichotikulCFO & Member of Executive Board · b. 1995
Ms. Pijittra SinroumGM & Member of Executive Board · b. 1979
Ms. Rawiwan LimwachirakhomMember of Executive Board & Director of Sales and Marketing · b. 1984
Ms. Nareerat ChatkunakornChief Accountant & Accounting Manager

Financials

Income Statement

Currency: THB	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	435.63M	352.71M	371.82M	1.76B	1.97B	2.19B	2.41B	2.32B	2.25B
Growth (%)	-	-19.03%	+5.42%	+373.44%	+12.18%	+11.12%	+9.93%	-3.68%	-3.01%
Cost of Revenue	335.96M	264.66M	269.55M	1.44B	1.63B	1.88B	2.08B	1.98B	1.91B
Gross Profit	99.68M	88.05M	102.27M	318.68M	346.87M	316.94M	332.80M	345.75M	342.14M
Gross Margin	22.88%	24.96%	27.50%	18.10%	17.57%	14.44%	13.80%	14.88%	15.18%
Operating Expense	73.14M	73.72M	74.82M	239.83M	250.63M	234.91M	264.51M	250.91M	322.27M
Operating Income	26.53M	14.33M	27.44M	78.84M	96.24M	82.03M	68.29M	94.84M	19.87M
Operating Margin	6.09%	4.06%	7.38%	4.48%	4.87%	3.74%	2.83%	4.08%	0.88%
EBITDA	26.53M	22.13M	45.84M	93.42M	113.61M	97.75M	84.74M	113.53M	40.06M
EBITDA Margin	6.09%	6.27%	12.33%	5.31%	5.75%	4.45%	3.51%	4.89%	1.78%
Net Income	19.12M	6.83M	36.57M	54.45M	72.40M	55.91M	50.70M	65.04M	38.47M
Net Income Margin	4.39%	1.94%	9.84%	3.09%	3.67%	2.55%	2.10%	2.80%	1.71%
Interest Expense	4.34M	4.41M	18.02M	9.07M	9.94M	6.27M	1.89M	2.63M	1.20M
Interest Expense % of Total Revenue	1.00%	1.25%	4.85%	0.52%	0.50%	0.29%	0.08%	0.11%	0.05%

Balance Sheet

Currency: THB	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	333.71M	329.86M	311.50M	814.63M	919.11M	1.09B	1.23B	1.25B	1.26B
Total Liabilities	186.74M	176.06M	222.43M	601.79M	652.28M	316.59M	437.59M	438.87M	459.77M
Total Equity	146.97M	153.80M	89.07M	215.07M	265.48M	761.00M	779.85M	802.14M	782.98M
Cash	12.54M	27.72M	17.10M	25.60M	72.46M	22.44M	25.30M	128.09M	52.30M
Total Debt	87.87M	86.88M	61.44M	255.29M	311.91M	6.63M	6.85M	55.97M	6.19M
Net Debt	75.33M	59.17M	44.34M	229.69M	239.45M	-15.80M	-18.45M	-72.12M	-46.12M

Cash Flow

Currency: THB	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	182.56M	22.42M	36.73M	-32.74M	-22.56M	104.40M	274.23M
Investing Cash Flow	50.67M	-50.08M	-15.44M	-142.58M	61.59M	-1.19M	-244.65M
Financing Cash Flow	-212.02M	-44.43M	25.57M	125.30M	-36.25M	657.00K	-105.36M
Capital Expenditure	20.96M	26.49M	19.96M	17.59M	8.40M	7.03M	2.16M
Free Cash Flow	161.60M	-4.07M	16.77M	-50.33M	-30.97M	97.37M	272.07M
Dividends Paid	112.69M	69.70M	22.00M	109.04M	32.19M	37.68M	53.38M
FCF to OCF	88.52%	-18.14%	45.67%	153.74%	137.25%	93.26%	99.21%
Dividend Paid to FCF	69.73%	-1713.84%	131.16%	-216.63%	-103.94%	38.70%	19.62%

Earnings

Report Date	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.04	0.04	0.04	0.02	0.04	0.05	0.05	0.04	0.05	0.05	0.06	0.06	0.06	0.03	-0.03	0.06	0.05
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap803.84M

Enterprise Value593.60M

Trailing P/E23.27

Forward P/E0.00

Price / Sales0.36

Price / Book1.05

EPS0.11

Book Value2.53

Revenue (TTM)2.23B

Gross Profit (TTM)313.49M

EBITDA60.98M

Profit Margin1.53%

Operating Margin3.65%

Return on Equity4.69%

Return on Assets2.42%

Shares Outstanding314.00M

Shares Float116.62M

Beta0.51

Dividend Yield4.69%

Dividend Rate0.12

Payout Ratio2.38%

Dividends

20262×

0.23Aug 24, 20260.04Apr 29, 2026

20252×

0.08Aug 20, 20250.09Apr 30, 2025

20242×

0.05Aug 27, 20240.07May 2, 2024

20232×

0.04Aug 24, 20230.06May 2, 2023

20221×

0.06Aug 24, 2022